News
On September 1, 2026, the United States District Court for the Middle District of Tennessee granted preliminary approval of a settlement agreement resolving the derivative action, under which defendants have agreed to implement various corporate reforms and pay $12 million to Acadia Healthcare.
On August 24, 2026, the United States District Court for the Southern District of California granted preliminary approval of a settlement resolving the derivative action, under which defendants have agreed to implement various corporate reforms.
In a complaint filed on August 14, 2026 on behalf of Medical Properties Trust, plaintiff alleges, among other things, that certain of the company’s officers and directors breached their fiduciary duties, abused their control, grossly mismanaged the company, wasted corporate assets, and were unjustly enriched.
In a complaint filed on July 10, 2026 against Rivian Automotive, plaintiff alleges that defendants breached their fiduciary duties, engaged in insider trading, and unjustly enriched themselves.
In a complaint filed on May 22, 2026, plaintiffs allege that Aon and certain of its officers and directors breached their fiduciary duties and seek over $120 million in alleged damages.
In an order entered on May 21, 2026, the Delaware Court of Chancery stayed a shareholder derivative action brought by KSF on behalf of Acadia Healthcare in light of the parties’ agreement in principle to settle the claims asserted therein and in certain related derivative actions.
In a status report filed on May 19, 2026, the parties to a shareholder derivative action brought on behalf of Acadia Pharmaceuticals in California federal court advised that they had substantially completed documenting a settlement of the claims asserted therein and in certain related stockholder demands, including a stockholder demand served by KSF.
KSF filed an ERISA class action complaint on April 17, 2026, against Providence Health & Services, St. Joseph Health System, and certain of their officers and directors alleging that defendants breached their fiduciary duties.
Plaintiffs allege that defendants breached their fiduciary duties by, among other things, failing to divest underperforming investments, engaging in transactions prohibited by ERISA.
Plaintiffs allege that defendants breached their fiduciary duties by, among other things, failing to divest underperforming investments, engaging in transactions prohibited by ERISA.
In a complaint filed on January 28, 2026, plaintiffs allege that Dell and certain of its officers and directors breached their fiduciary duties and seek over $318 million in alleged damages.
Kahn Swick & Foti, LLC Announces Proposed Settlement of Purecycle, Inc. Stockholder Derivative Litigation
Kahn Swick & Foti, LLC Announces Proposed Settlement of Borgwarner Stockholder Derivative Litigation
The Hon. Mary Kay Vyskocil granted final approval to the shareholder derivative settlement in In re Conduent Incorporated Stockholder Derivative Litigation
The Court approved the settlement of the stockholder derivative action brought on behalf of Twitter, Inc. (“Twitter”) against several of Twitter’s current and former directors and officers for breach of fiduciary duties.
Kahn Swick & Foti, LLC Announces Proposed Settlement of Twitter, Inc. Stockholder Derivative Litigation
KSF’s stockholder derivative action was brought on behalf of Twitter, Inc. (“Twitter”) against several of Twitter’s current and former directors and officers for breach of fiduciary duties. On December 17, 2020, plaintiffs were able to secure a settlement providing that Twitter’s board of directors will pay $38 million in cash to Twitter and $8.75 million in attorney fees and court costs.
On November 29, 2020, Vice Chancellor Joseph R. Slights III of the Delaware Court of Chancery granted final approval to the shareholder derivative settlement in In re Fitbit, Inc. Stockholder Derivative Litigation.
Download Fitbit Settlement Documents
Vice Chancellor Joseph R. Slights III of the Delaware Chancery Court rejected a motion to dismiss a stockholder derivative suit alleging insider trading and breach of fiduciary duty claims against executive officers and directors of Fitbit, Inc.